Meadows to meet with FDA chief as Trump asks about vaccine emergency approval status

By
Rex Rose
Meadows to meet with FDA chief as Trump asks about vaccine emergency approval status

Meadows summed up Hen for a weekend progress update. Hahn requested his meeting over the phone, a source said, but was told by the White House that the chief of staff preferred to meet face-to-face. It appears there are concerns within the FDA that the meeting could be tense, with Hane giving a statement to Axis on Monday night defending the FDA’s timeline.

“Let me be clear – our career scientists will have to make a decision and they will take the necessary time to make the right call on this important decision.” Said In the statement.
Pfizer Applied for Emergency Use Authorization November 20. Emergency use approval from the FDA is not the same as full approval but according to a previous CNN report, all evidence allows products to be used in special circumstances before they become available for approval. The FDA had earlier said it had scheduled a meeting of an outside advisory panel on December 10 to discuss Pfizer and Bioentech’s application for emergency use approval for the coronavirus vaccine.

But Trump is privately disappointed at how long the process will take, sources told CNN. He has proudly and publicly acknowledged putting pressure on the FDA to move quickly.

“It could have taken four or five years to do this,” Trump told reporters about the progress of the vaccine on Thanksgiving. “Normally, it would probably take four or five years to get through the FDA. We pushed it very hard.”

Amid the president’s complaint that the FDA is working too slowly, White House Press Secretary Kyle McKinney told Fox News on Tuesday that the agency works “twenty-four hours a day” but said Trump would never apologize for setting fires under these agencies. “

See also  Unachievable, Blue Bottle and Shake Shack: How major US food stuff brands pivot during coronavirus

“We need a safe vaccine, absolutely. We also need a fast one because lives are at stake and a vaccine by the end of the year is key and paramount,” McNeny said.

It is not clear how the meeting between Meadows and Hehan will go on until it is over. A sense of distrust already exists between Trump’s closest advisers and career scientists at the FDA, the FDA said in a statement on Monday night.

“The FDA has been preparing an EU review for the Covid-19 vaccine for several months and is ready to do so as soon as the EU request is presented,” Hahn said in a statement, referring to the vaccine in late November immediately after Pfizer applied for emergency use. “While we cannot predict how long the FDA’s review will take, the FDA will review the request as quickly as possible, while still doing so in a thorough and scientific way, so that we can help make the American people’s vaccine available. As soon as possible.” Character. “

RELATED ARTICLESMORE FROM AUTHOR

LEAVE A REPLY

Please enter your comment!
Please enter your name here